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ABSTRACT
Objective: This current study was carried out to determine the in vitro α-amylase and α-glucosidase inhibitory activity of extract and fractions of 
Albizia procera.
Methods: The α-amylase and α-glucosidase inhibition assay was carried out at concentrations 50–2000 µg/ml and acarbose used as standard. The 
absorbance was measured at 540 nm and recorded by spectrophotometer. Percentage inhibition was calculated for both the assays. Preliminary 
phytochemical screening was also evaluated using standard procedures.
Results: There was a dose-dependent percentage inhibition of extracts (petroleum ether and ethanol) and fractions (chloroform, ethyl acetate, and 
n-butanol). The ethanol extract and n-butanol fraction show good inhibitory activity against both α-amylase and α-glucosidase with the percentage 
inhibition of 86.20% and 88.20% and 83.13% and 87.10%, respectively. The preliminary phytochemical screening shows that ethanol extract consists 
of active constituents such as flavonoids and phenolic compounds and tannins.
Conclusion: This finding suggests that the ethanol extract and n-butanol fraction show good inhibitory activity against both α-amylase and 
α-glucosidase and show good antidiabetic activity.
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INTRODUCTION
Diabetes mellitus is a very complicated disease, which can lead to 
nerve damage and kidney failure, atherosclerosis, blindness, stroke, 
and heart diseases. There are about 8.3 million diabetics in the United 
States, of which about 600,000 suffer from type 1 (insulin-dependent) 
diabetes [1]. The incidence is far higher among some ethnic groups, in 
which diet play a major role. 50% of group of native Americans (Pima) 
over 40 years of age have diabetes. Diabetes is the fifth leading cause 
of death in the U.S. as well as the leading cause of adult blindness due 
to diabetic retinopathy and is responsible for 50% of heart attacks, 
75% of strokes, and 85% of gangrenous leg amputation due to diabetic 
peripheral neuropathy [2,3].
Developing countries are the most affected because of expensive 
and inadequate treatment associated with the synthetic oral 
hypoglycemic agents. The treatment from medicinal plants exhibits 
potential agonistic/antagonistic pharmacological agents within 
themselves due to incorporation of bioactive constituents with 
variety of pharmacological actions with minimal side effects. These 
pharmacological principles work together in a dynamic way to produce 
maximum therapeutic efficacy. There are wide varieties of traditional 
medicines used for the treatment of diabetes and can combat the threat 
of diabetic epidemic [4,5].
This plant is used traditionally for the treatment of cancer, convulsions, 
delirium, and septicemia. The decoction of bark is used traditionally 
for rheumatism and hemorrhage and is considered useful in treating 
pregnancy problems, stomach ache, and sinus [6,7]. They were 
reported to exhibit various pharmacological activities such as CNS 
activity, cardiotonic activity, lipid-lowering activity, anti-oxidant 
activity, hepatoprotective activity, and hypoglycemic activity. The leaves 
of Albizia procera were used for the treatment of variety of wounds 
and also to suppress skin diseases [8,9]. Seeds are powdered and used 
in amoebiasis. It cures urinary tract infections including glycosuria, 
hemorrhoids, fistula, and worm infestation. Fruits of A. procera act as 
astringent and diminish Kapha and Sukra. In India, leaves are used for 
the treatment of ulcers [10,11].
METHODS
Collection of plant
The bark of A. procera was collected from Chennai (near Melur, Madurai), 
Tamil Nadu, India. The plant material was identified and authenticated 
by Dr. K.N. Sunil Kumar R.O. and HOD Pharmacognosy, Central Siddha 
Research Institute, Government of India, Arumbakkam, Chennai-106, 
authentication code (A17062401P). The bark was dried under shade, 
segregated, pulverized by a mechanical grinder, and passed through a 
40-mesh sieve.
Preparation of plant extracts
The dried powder of bark was extracted sequentially by hot continuous 
percolation method by Soxhlet apparatus, using petroleum ether and 
ethanol as solvent. The extracts were concentrated using a rotary 
evaporator.
Phytochemical screening of extracts from A. procera
The extract was subjected to preliminary qualitative test for the extracts 
to identify the phytoconstituents present in the bark [12,13].
Fractionation of active extract
Ethanol extract comprises of flavonoids, tannins, and phenolic 
compounds, and hence, ethanol extract has been selected for further 
fractionation using solvents, chloroform, ethyl acetate, and n-butanol. 
Ethanol extract was filtered through a Buchner funnel fitted with 
a vacuum pump with a thin layer of activated charcoal and then 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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concentrated using a rotary evaporator. The solvent is recovered and 
the residue is dried. The crude dried ethanol extract was partitioned 
between equal volumes (250 ml each) of distilled water and chloroform. 
It was shaken for some time and the chloroform layer was separated 
and concentrated to get a residue, which is considered as chloroform 
fraction. The aqueous layer which is present was again fractionated 
by the solvent ethyl acetate. It will be shaken for some time, and ethyl 
acetate layer was separated and concentrated to get a residue which 
is considered as ethyl acetate fraction. The aqueous layer was again 
fractionated by the solvent n-butanol. It was shaken for sometimes 
and n-butanol layer was separated, concentrated to get a residue, and 
considered as n-butanol fraction. The aqueous fraction which was 
remained finally was not used for further study.
In vitro antidiabetic activity
α-amylase assay
α-amylase was dissolved in phosphate buffer saline (PBS, 0.02 mol/L, 
pH 6.8) at a concentration of 0.1 mg/mL. Various concentrations of 
extracts and fractions of 50 µg/ml–2000 µg/ml (0.25 mL) were mixed 
with α-amylase solution (0.25 mL) and incubated at 37°C for 5 min. 
Then, the reaction was initiated by adding 0.5 mL 1.0% (w/v) starch 
substrate solution to the incubation medium. After incubation at 37°C 
for 3 min, the reaction was stopped by adding 0.5 mL DNS reagent 
(1% dinitrosalicylic acid, 0.05% Na2SO3, and 1% NaOH solution) to the 
reaction mixture, and it was boiled at 100°C for 5 min. After cooling to 
room temperature, the absorbance (Abs) was measured at 540 nm and 
recorded by a spectrophotometer [14,15]. The inhibition percentage 
was calculated by the following equation:
Inhibition (%) = [(Abs1 − Abs2)/Abs1]×100
where Abs1=sample and Abs2 = control
α-glucosidase assay
α-glucosidase was dissolved in PBS (0.02 mol/L, pH 6.8 at a concentration 
of 0.1 mg/mL [16]. Various concentrations of extracts and fractions 
of 50 µg/ml–2000 µg/ml (0.25 mL) were mixed with α-glucosidase 
solution (0.25 mL) and incubated at 37°C for 5 min. Then, the reaction 
was initiated by adding 0.5 mL 1.0% (w/v) starch substrate solution to 
the incubation medium. After incubation at 37°C for 3 min, the reaction 
was stopped by adding 0.5 mL DNS reagent (1% dinitrosalicylic acid, 
0.05% Na2SO3, and 1% NaOH solution) to the reaction mixture, and it 
was boiled at 100°C for 5 min. After cooling to room temperature, the 
Abs was measured at 540 nm and recorded by a spectrophotometer [17]. 
The inhibition percentage was calculated by the following equation:
Inhibition (%) = [(Abs1 − Abs2)/Abs1]×100
Where Abs1=sample and Abs2 = control.
RESULTS
In alpha-glucosidase inhibition assay, as illustrated in Table 3, it reveals that 
ethanol extract has greater alpha-glucosidase inhibition with the percentage 
inhibition of 88.2027 at 2000 µg/ml. Petroleum ether extract shows the 
percentage inhibition of 59.90% at 2000 µg/ml. The ethanol extract shows 
greater α-amylase and α-glucosidase inhibition than standard acarbose.
As described in Table 4, the fractions, chloroform, ethyl acetate, and 
n-butanol also have greater alpha-amylase inhibition than standard 
acarbose. n-butanol fraction has greater alpha-amylase inhibition 
than chloroform and ethyl acetate fraction. The percentage inhibition 
of n-butanol fraction against alpha-amylase was found to be 83.104%. 
Interestingly, it was observed that n-butanol fraction has greater alpha-
amylase inhibition than standard acarbose with 79.37% inhibition. The 
results of extracts and fractions against alpha-amylase are also depicted 
in Figs. 1 and 2.
As described in Table 5, the fractions, chloroform, ethyl acetate, and 
n-butanol also have greater alpha-glucosidase inhibition than standard 
acarbose. The n-butanol fraction has greater alpha glucosidase 
inhibition than chloroform and ethyl acetate fraction. The percentage 
inhibition of n-butanol fraction against alpha-glucosidase is found to 
be 87.100%. The n-butanol fraction has greater alpha-glucosidase 
inhibition than standard acarbose with 74.37% inhibition. The results 
of extracts and fractions against alpha-amylase are also depicted in 
Figs. 3 and 4.
DISCUSSION
Table 1: Preliminary phytochemical analysis on bark extracts of 
A. procera
S.NO Test Petroleum ether Ethanol
1 Alkaloids - _
2 Carbohydrates and glycosides - +
3 Phytosterols + +
4 Triterpenoids + +
5 Flavonoids - +
6 Phenolic compounds and tannins - +
7 Protein and amino acid - _
8 Saponins - +
9 Fixed oils and fats + _
+: Positive, -: Negative. A. procera: Albizia procera
Table 2: Effect of extracts on percentage inhibition of α-amylase







Each value in the table was obtained by calculating the average of three 
experiments and data are presented as mean±SEM
Table 3: Effect of extracts on percentage inhibition of 
α-glucosidase







Each value in the table was obtained by calculating the average of three 
experiments, and data are presented as Mean±SEM
From the preliminary phytochemical screening, it was observed that
 ethanol  extract  consists  of  active constituents  such as  flavonoids 
and  phenolic  compounds  and  tannins.  While  petroleum  ether  extract 
shows the presence of phytosterols, triterpenoids, and fats (Table 1). 
Hence,  ethanol  extract  was  chosen  for  in  vitro  antidiabetic  study  since 
flavonoids  and  phenolic  compounds  play  a  major  role  in  diabetic 
research.
In alpha-amylase inhibition assay, as illustrated in Table 2, reveals 
that ethanol extract has greater alpha amylase inhibition with the 
percentage inhibition of 86.20% at 2000 µg/ml. The petroleum ether 
extract shows weak percentage inhibition of 57.11% at 2000 µg/ml.
The antioxidants (tannins, flavonoids, Vitamins C and E, etc.) have 
the capacity to prevent the destruction of β-cells by inhibiting the 
peroxidation chain reaction, by which they may provide protection 
against the development of diabetes [18]. The mechanism of tannins as 
antidiabetic activity is by Mitogen-Activated Protein Kinase activation 
and GLUT-4 translocation [19,20]. The protective effects of flavonoids 
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against diabetes are by (a) acting as free radical scavengers and (b) 
activating antioxidant enzymes which may be suppressed by the 
oxidative stress induced by hypoglycemia [21]. Moreover, fibers of 
plants may also interfere in the absorption of carbohydrates and thus 
may have an effect on blood glucose [22].
The extracts and fractions of A. procera showed significant α-amylase 
inhibitory activity. α-amylases catalyze the hydrolysis of α-1, 
4-glucosidic linkage of starch to initiate starch digestion and promote 
glucose absorption. α-amylase inhibitors were considered to be 
effective in diabetes control [23]. The extracts and fractions of A. procera 
also show significant α-glucosidase inhibitory activity. α-glucosidase 
constitutes a family of enzymes hydrolase, located in the brush-border 
surface membrane of small intestinal cells, and it is the key enzyme by 
which the final step of digestion is catalyzed [24]. Hence, glucosidase 
inhibitors can stop the liberation of D-glucose from complex dietary 
carbohydrates and can delay the glucose absorption which in turn 
Table 4: Effect of fractions of A. procera on percentage inhibition of α-amylase
Concentration µg/ml Chloroform fraction Ethyl acetate fraction n-butanol fraction Acarbose (standard)
50 1.31004±0.04 0.87719±0.07 14.41860±0.04 5.04202±0.06
100 28.7066±0.06 23.1293±0.05 24.27983±0.07 21.7993±0.05
250 43.7811±0.03 48.2838±0.03 46.51162±0.05 34.1108±0.04
500 64.5768±0.09 73.2861±0.06 66.6061±0.09 42.9293±0.07
1000 79.5104±0.07 84.5417±0.02 81.6410±0.03 53.4979±0.06
2000 81.6467±0.02 80.822±0.04 83.1304±0.02 79.3764±0.04
Each value in the table was obtained by calculating the average of three experiments and data are presented as Mean±SEM. A. procera: Albizia procera
Table 5: Effect of fractions of A. procera on percentage inhibition of α- glucosidase
Concentration (µg/ml level) Chloroform fraction Ethyl acetate fraction n-butanol fraction Acarbose Standard
50 2.30004±0.04 1.90719±0.05 16.40860±0.05 5.04202±0.06
100 29.7066±0.06 25.1093±0.07 27.27983±0.08 21.7993±0.08
250 51.7811±0.06 50.2838±0.11 49.51162±0.12 34.1108±0.07
500 68.5768±0.08 76.2861±0.15 70.6061±0.10 42.9293±0.05
1000 80.5014±0.07 82.0017±0.17 81.6010±0.05 53.4979±0.03
2000 83.6067±0.04 82.902±0.06 87.1004±0.04 74.3764±0.04
Each value in the table was obtained by calculating the average of three experiments and data are presented as Mean±SEM
Fig. 1: α-amylase inhibition assay of extract and fractions from 
Albizia procera. E - Ethanolextract, C - Chloroform extract, EA - 
Ethyl acetate fraction, PE - Petroleum ether fraction,
Acarbose (Standard
Fig. 2: α-amylase inhibition assay of n-butanol (n-BT) fraction of 
Albizia procera
Fig. 3: α-glucosidase inhibition assay of extract and fractions from 
Albizia procera. E - Ethanol extract, C - Chloroform extract, EA - 
Ethyl acetate fraction, PE - Petroleum ether fraction, Acarbose 
(Standard)
Fig. 4: α-glucosidase inhibition assay of n-butanol (n –BT) fraction 
from Albizia procera
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reduce blood glucose level and decrease hyperglycemia [25,26]. In this 
present study, in vitro α-amylase and α-glucosidase inhibitor activity 
of extracts and fractions of A. procera stem bark were evaluated. The 
retardation and delay of carbohydrate absorption with a plant-based 
α-amylase and α-glucosidase inhibitor offer a prospective therapeutic 
approach for the management of type 2 diabetes mellitus.
CONCLUSION
From above these observations, it is concluded that the ethanol extract 
and n-butanol fraction of A. procera have good in vitro antidiabetic 
activity by evaluating against alpha-amylase and alpha-glucosidase 
inhibition assay. The flavonoids and phenolic compounds present in 
ethanol extract may be responsible for the in vitro antidiabetic activity. 
However, the active principles responsible for inhibitory action of 
α-amylase and α-glucosidase need to be identified and characterized 
for the development of indigenous botanical resources for novel 
hypoglycemic drug development.
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